By the end of 2029, the market for treatments for canine atopic dermatitis is expected to surpass US$ 2.37 billion. The market is expected to grow as greater focus is given on the discovery of new therapies, such as monoclonal antibodies, for the treatment of atopic dermatitis in dogs and cats. The market for treatments …